ALNY icon

Alnylam Pharmaceuticals

237 hedge funds and large institutions have $6.73B invested in Alnylam Pharmaceuticals in 2015 Q1 according to their latest regulatory filings, with 47 funds opening new positions, 106 increasing their positions, 59 reducing their positions, and 22 closing their positions.

Holders
237
Holders Change
+22
Holders Change %
+10.23%
% of All Funds
6.32%
Holding in Top 10
12
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+20%
% of All Funds
0.32%
New
47
Increased
106
Reduced
59
Closed
22
Calls
$84.9M
Puts
$63.7M
Net Calls
+$21.2M
Net Calls Change
+$5.1M
Name Market Value Shares Shares
Change
Shares
Change %
Fidelity Investments
1
Fidelity Investments
Massachusetts
$1.31B 12,564,021 +1,024,358 +9%
Wellington Management Group
2
Wellington Management Group
Massachusetts
$1.09B 10,440,814 +1,493,678 +17%
Vanguard Group
3
Vanguard Group
Pennsylvania
$452M 4,327,986 +607,212 +16%
Capital World Investors
4
Capital World Investors
California
$223M 2,138,700 +1,173,388 +122%
UBS AM
5
UBS AM
Illinois
$185M 1,774,292 +172,538 +11%
BIT
6
BlackRock Institutional Trust
California
$184M 1,759,334 +156,051 +10%
GGHC
7
Gilder Gagnon Howe & Co
New York
$183M 1,748,367 -201,902 -10%
BFA
8
BlackRock Fund Advisors
California
$177M 1,692,612 +237,280 +16%
Morgan Stanley
9
Morgan Stanley
New York
$146M 1,399,525 +24,119 +2%
T. Rowe Price Associates
10
T. Rowe Price Associates
Maryland
$132M 1,261,604 +19,578 +2%
First Trust Advisors
11
First Trust Advisors
Illinois
$131M 1,254,525 +396,842 +46%
State Street
12
State Street
Massachusetts
$121M 1,160,599 +89,989 +8%
Franklin Resources
13
Franklin Resources
California
$118M 1,126,045 -1,012,441 -47%
Artisan Partners
14
Artisan Partners
Wisconsin
$113M 1,084,560 +793,178 +272%
Baillie Gifford & Co
15
Baillie Gifford & Co
United Kingdom
$107M 1,023,430 -70,000 -6%
BRC
16
Blue Ridge Capital
New York
$100M 960,000 +530,000 +123%
Jennison Associates
17
Jennison Associates
New York
$98.8M 945,847 +2,876 +0.3%
AWG
18
Alpha Wave Global
New York
$91M 871,713 -496,000 -36%
SPC
19
Slate Path Capital
New York
$89.3M 855,000
BB
20
BB Biotech
Switzerland
$87.2M 835,499 +84,211 +11%
Wells Fargo
21
Wells Fargo
California
$81.2M 778,025 -42,090 -5%
1WCM
22
12 West Capital Management
New York
$68M 651,000
BM
23
Bridger Management
New York
$65.4M 626,758 +62,319 +11%
Norges Bank
24
Norges Bank
Norway
$62.2M 595,294 +42,633 +8%
Goldman Sachs
25
Goldman Sachs
New York
$62.1M 595,105 +38,829 +7%